RE: Seller26 Mar 2018 10:56
This share is most definitely a buy and hold. I’ve had them since before we were originally suspended and topped up on the relist under this name. It has plenty of potential, but companies don’t boom overnight. The foundations are being built quickly and solidly in biotech terms.